BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20701970)

  • 1. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
    Wilkins BS
    Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant proplatelet formation in chronic myeloproliferative neoplasms.
    Muth M; Büsche G; Bock O; Hussein K; Kreipe H
    Leuk Res; 2010 Nov; 34(11):1424-9. PubMed ID: 20430444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic conference. Chronic myeloproliferative disease with an increase in platelet count in the differential diagnosis of primary (essential, idiopathic) thrombocythemia (PTH)].
    Zankovich R; Thiele J; Fischer R; Diehl V
    Med Klin (Munich); 1986 Jan; 81(1):31-5. PubMed ID: 3785010
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormal clones of megakaryocytes in myeloproliferative disorders.
    Sato Y; Suda T
    Nihon Ketsueki Gakkai Zasshi; 1986 Dec; 49(8):1705-18. PubMed ID: 3471029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract]   [Full Text] [Related]  

  • 7. Mixed myelodysplastic syndrome and myeloproliferative disorder with bone marrow and pulmonary fibrosis: the role of megakaryocytes.
    Rosenstingl S; Brouland JP; Zini JM; Tobelem G; Dupuy E
    Acta Haematol; 2003; 109(3):145-9. PubMed ID: 12714825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?].
    Wehmeier A; Schneider W
    Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary myelofibrosis is the most frequent myeloproliferative neoplasm associated with del(5q): clinicopathologic comparison of del(5q)-positive and -negative cases.
    Santana-Davila R; Tefferi A; Holtan SG; Ketterling RP; Dewald GW; Knudson RA; Steensma DP; Chen D; Hoyer JD; Hanson CA
    Leuk Res; 2008 Dec; 32(12):1927-30. PubMed ID: 18538839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow in megakaryocytic disorders.
    Burkhardt R
    Hematol Oncol Clin North Am; 1988 Dec; 2(4):695-733. PubMed ID: 3065325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detangling fibrosis assessment in MPNs.
    Mesa RA
    Leuk Res; 2010 Jul; 34(7):854-5. PubMed ID: 20137811
    [No Abstract]   [Full Text] [Related]  

  • 12. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Atypical myeloproliferative disorders: a study on 3 cases showing pancytopenia, marrow fibrosis and the absence of splenomegaly].
    Yoshida Y; Yamagishi M; Fukuhara S; Sawada H; Ohkuma M; Uchino H; Nakamura T
    Rinsho Ketsueki; 1984 Mar; 25(3):383-92. PubMed ID: 6471435
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of the myeloproliferative syndrome from the pathologist's viewpoint].
    Werner W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):227-34. PubMed ID: 4184585
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute myelofibrosis.
    Rupani M
    Am J Clin Pathol; 1982 Apr; 77(4):475-8. PubMed ID: 6951405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of myelofibrosis in chronic myeloproliferative disorders].
    Nagao T; Yonekura S
    Rinsho Ketsueki; 1988 Jul; 29(7):983-8. PubMed ID: 2846914
    [No Abstract]   [Full Text] [Related]  

  • 17. [Bioptic medullary findings for the formation of fibres in attended and not yet attended myeloses (author's transl)].
    Hill K; Dennhardt HH
    Verh Dtsch Ges Pathol; 1972; 56():587-92. PubMed ID: 4130904
    [No Abstract]   [Full Text] [Related]  

  • 18. Classification of myeloproliferative disorders by bone marrow histology.
    Frisch B; Bartl R; Burkhardt R; Jäger K; Mahl G; Kettner G
    Bibl Haematol; 1984; (50):57-80. PubMed ID: 6590039
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary myelofibrosis and its paraneoplastic stromal effects.
    Tefferi A
    Haematologica; 2007 May; 92(5):577-9. PubMed ID: 17488678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Secondary myeloid splenomegalies and accompanying myeloid splenomegalies].
    Gallais H; Casanova P; Muratore R; Olmer J
    Nouv Presse Med; 1972 Apr; 1(16):1063-4. PubMed ID: 5035860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.